生成性人工智能在炎症性肠道疾病中的应用:系统性审查
Francesca Lusetti1, Stiliano Maimaris2, Gianmaria Pio La Rosa2
1Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy; IBD Unit, Gastroenterology Unit, Rho Hospital, ASST Rhodense, Rho MI, Italy.
概括
生成型人工智能在炎症性肠病 (IBD) 护理中显示出潜力,用于患者教育和决策支持,但由于准确性和一致性问题,需要专家监督.
科学领域:
- 医疗信息学 医疗信息学
- 医疗保健中的人工智能
- 胃肠病学 胃肠病学
背景情况:
- 炎症性肠道疾病 (IBD) 是全球健康的重大负担.
- 包括ChatGPT在内的生成人工智能 (AI) 正在成为医疗实践中的工具.
- 人工智能产生的医疗信息的可靠性和一致性存在担忧.
研究的目的:
- 系统地审查当前关于在IBD管理中应用生成AI的证据.
- 评估人工智能工具在患者教育,临床决策支持和IBD内的研究构想方面的表现.
主要方法:
- 按照PRISMA指南进行了一次系统的文献审查.
- 通过对PubMed和Embase数据库进行全面搜索来确定研究.
- 该搜索从2020年1月到2024年9月进行,重点关注IBD护理中的生成AI.
主要成果:
- 在2023-2024年间发表的8项研究符合纳入标准.
- 人工智能在患者教育 (84.2%的准确率) 和临床决策支持 (80-87.8%与临床医生一致) 中表现出有效性.
- 人工智能产生了相关的研究问题,但缺乏特异性和原创性.
结论:
- 生成型人工智能有望提高IBD护理的各个方面.
- 准确性,一致性和数据及时性的关键问题需要仔细考虑.
- 在将AI广泛纳入IBD管理之前,专家临床监督至关重要.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
241
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
241
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
Inflammatory Bowel Disease II: Crohn's Disease
129
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
129
Inflammatory Bowel Disease I: Ulcerative Colitis
98
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
98
Inflammatory Bowel Disease V: Surgical Management
65
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
65


